Genotype and clinical phenotype characteristics of MAX germline mutation–associated pheochromocytoma/paraganglioma syndrome
<i>MAX</i> germline mutations may cause new types of multiple endocrine neoplasia. A comprehensive baseline assessment of neural crest cell-derived diseases is recommended for all individuals with <i>MAX</i> germline mutations. The risk of bilateral and metastatic PCCs should also be considered.
Authors
- Xiao-Ping Qi (ORCID: https://orcid.org/0000-0003-1543-0727)
- Hongyuan Yu (ORCID: https://orcid.org/0000-0003-4208-1200)
- Feiping Li
- Xu-Dong Fang
- Bijun Lian (ORCID: https://orcid.org/0000-0001-9387-2120)
- Yiming Zhang (ORCID: https://orcid.org/0000-0002-8933-1871)
- Wang Jun-wei (ORCID: https://orcid.org/0000-0002-6464-8880)
- Wei Wang (ORCID: https://orcid.org/0000-0003-2642-3338)
- Weiying Chen
- Jun Lü (ORCID: https://orcid.org/0009-0000-6292-2252)
- Yi He
Institutions
- Second Military Medical University (CN)
- Wenzhou Medical University (CN)
- Jiaxing University (CN)
- Changhai Hospital (CN)
- First Hospital of Jiaxing (CN)
- The First People's Hospital of Tianmen (CN)
- Zhejiang Taizhou Hospital (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.3389/fendo.2024.1442691
- Citations
- 9
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 5.15
Funders
- National Natural Science Foundation of China
- Medical Science and Technology Project of Zhejiang Province
- Science and Technology Program of Zhejiang Province